mRNA expression levels of the biological factors uPAR, uPAR-del4/5, and rab31, displaying prognostic value in breast cancer, are not clinically relevant in advanced ovarian cancer
Authors:
- 18 August 2011
- journal article
- research article
- Published by Walter de Gruyter GmbH in Biological Chemistry
- Vol. 392 (11) , 1047-1051
Abstract
High tumor tissue mRNA expression of the tumor biological factors uPAR, uPAR-del4/5, or rab31 is associated with shorter distant metastasis-free and overall survival in breast cancer patients. To evaluate whether these factors are also clinically relevant in ovarian cancer, we quantified the respective mRNA levels in primary tumor tissue of advanced ovarian cancer patients (n=103) and evaluated their association with clinicopathological parameters and patients’ prognosis. mRNA expression levels of all three markers did not show any significant association with overall or progression-free survival, demonstrating that these factors have no prognostic value in advanced ovarian cancer.Keywords
This publication has 24 references indexed in Scilit:
- Role of Rab GTPases in Membrane Traffic and Cell PhysiologyPhysiological Reviews, 2011
- Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancerAnnals of Oncology, 2010
- Translational research on u-PAREuropean Journal of Cancer, 2010
- The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signalingFEBS Letters, 2009
- Cleaved Forms of the Urokinase Plasminogen Activator Receptor in Plasma Have Diagnostic Potential and Predict Postoperative Survival in Patients with Ovarian CancerClinical Cancer Research, 2008
- Primary Tumor Levels of Human Tissue Kallikreins Affect Surgical Success and Survival in Ovarian Cancer PatientsClinical Cancer Research, 2007
- Endocytic recycling pathways: emerging regulators of cell migrationCurrent Opinion in Cell Biology, 2006
- Emerging Role of RAB GTPases in Cancer and Human DiseaseCancer Research, 2005
- The RAB25 small GTPase determines aggressiveness of ovarian and breast cancersNature Medicine, 2004
- High tumor tissue concentration of urokinase plasminogen activator receptor is associated with good prognosis in patients with ovarian cancerInternational Journal of Cancer, 2003